{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:02:05Z","timestamp":1793124125055,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.ygyno.2014.04.013","type":"journal-article","created":{"date-parts":[[2014,5,28]],"date-time":"2014-05-28T04:18:02Z","timestamp":1401250682000},"page":"401-404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":301,"title":["2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer"],"prefix":"10.1016","volume":"133","author":[{"given":"David G.","family":"Mutch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Prat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2014.04.013_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ygyno.2014.04.013_bb0010","series-title":"World Health Organization Classification of Tumours: pathology and genetics of tumours of the breast and female genital organs","first-page":"117","article-title":"Surface epithelial stromal tumours: tumours of the ovary and peritoneum","author":"Lee","year":"2003"},{"issue":"3","key":"10.1016\/j.ygyno.2014.04.013_bb0015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00428-012-1203-5","article-title":"Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features","volume":"460","author":"Prat","year":"2012","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1016\/j.ygyno.2014.04.013_bb0020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"issue":"25","key":"10.1016\/j.ygyno.2014.04.013_bb0025","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.04.013_bb0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.ygyno.2014.04.013_bb0035","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/path.4263","article-title":"Through the glass darkly: intraepithelial neoplasia, top-down differentiation, and the road to ovarian cancer","volume":"231","author":"Crum","year":"2013","journal-title":"J Pathol"},{"key":"10.1016\/j.ygyno.2014.04.013_bb0040","series-title":"De Vita, Hellman, and Rosenberg's cancer: principles and practice of oncology. 9th ed","first-page":"1368","article-title":"Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma","author":"Cannistra","year":"2011"},{"issue":"3","key":"10.1016\/j.ygyno.2014.04.013_bb0045","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1525-1438.2007.01058.x","article-title":"Pathology of stage I versus stage III ovarian carcinoma with implications for pathogenesis and screening","volume":"18","author":"Yemelyanova","year":"2008","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2014.04.013_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PGP.0b013e3181af2372","article-title":"Prognostic factors for stage I ovarian carcinoma","volume":"29","author":"Seidman","year":"2010","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.04.013_bb0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/AOG.0b013e3181917a0c","article-title":"Influence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian cancer","volume":"113","author":"Bakkum-Gamez","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"95 Suppl. 1","key":"10.1016\/j.ygyno.2014.04.013_bb0060","first-page":"S161-92","article-title":"Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecologic cancer","author":"Heintz","year":"2006","journal-title":"Int J Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.ygyno.2014.04.013_bb0065","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ygyno.2007.09.014","article-title":"Metastatic lymphnode number in epithelial ovarian carcinoma: does it have any clinical significance?","volume":"108","author":"Ayhan","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.ygyno.2014.04.013_bb0070","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1555::AID-CNCR10>3.0.CO;2-R","article-title":"Patients with ovarian carcinoma upstaged to stage III after systemic lymphadenectomy have similar survival to Stage I\/II patients and superior survival to other stage III patients","volume":"83","author":"Onda","year":"1998","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2014.04.013_bb0075","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/gyno.1999.5349","article-title":"The validity and significance of substage IIIC by node involvement in ovarian cancer: impact of nodal metastasis on patient survival","volume":"73","author":"Kanazawa","year":"1999","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.ygyno.2014.04.013_bb0080","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/jnci\/dji102","article-title":"Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial","volume":"97","author":"Panici","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.ygyno.2014.04.013_bb0085","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ygyno.2006.08.047","article-title":"Is it justified to classify patients to stage IIIC epithelial ovarian cancer based on nodal involvement only?","volume":"103","author":"Cliby","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.04.013_bb0090","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ygyno.2007.05.016","article-title":"Ovarian cancer patients with \u201cnode positive-only\u201d Stage IIIC disease have a more favorable outcome than Sage IIIA\/B","volume":"107","author":"Ferrandina","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ygyno.2014.04.013_bb0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3802\/jgo.2008.19.4.223","article-title":"Stage IIIC epithelial ovarian cancer classified soley by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer","volume":"19","author":"Baek","year":"2008","journal-title":"J Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814008713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814008713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T20:55:36Z","timestamp":1538600136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814008713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0090825814008713"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.04.013","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}